Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Research Areas
Products Related to Obesity, Appetite Control & Diabetes(354)
- GC52390Spexin 1 (human, mouse, rat, bovine) (acetate)Purity: >98.00%
An endogenous peptide and agonist of GAL 2 and GAL 3
- GC5239810-oxo-12(Z)-Octadecenoic Acid ethyl esterPurity: >95.00%
An ester form of 10-oxo-12(Z)-octadecenoic acid
- GC5242810-oxo-12(Z)-Octadecenoic Acid-d5Purity: >99.00%
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid
- GC52453Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt)Purity: >98.00%
A peptide orexin receptor 1 agonist
- GC52504Human Vitamin D Receptor Reporter Assay SystemPurity: >98%
A nuclear receptor cell-based reporter assay
- GC52507Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt)Purity: >95.00%
A hypothalamic neuropeptide
- GC60871Gemigliptin tartrateCAS: 1374639-74-3Purity: >98.00%
Gemigliptin tartrate is a potent, selective and long-acting dipeptidyl peptidase 4 (DPP4) inhibitor with a K i of 7.25nM and an IC 50 value of 10.3nM.
- GC60997Lixisenatide acetateCAS: 1997361-87-1Purity: >98.50%
Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
- GC70855LSN3318839CAS: 2764704-18-7Purity: >99.00%
LSN3318839 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R).
- GC72096BamadutideCAS: 1596343-09-7Purity: >99.00%
Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist.
- GC72222SurvodutideCAS: 2805997-46-8Purity: >99.50%
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52388 | [D-Lys3]-GHRP-6 (trifluoroacetate salt) | - | >95.00% | |
An antagonist of GHS-R1a | ||||
| GC52390 | Spexin 1 (human, mouse, rat, bovine) (acetate) | - | >98.00% | |
An endogenous peptide and agonist of GAL 2 and GAL 3 | ||||
| GC52398 | 10-oxo-12(Z)-Octadecenoic Acid ethyl ester | - | >95.00% | |
An ester form of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52428 | 10-oxo-12(Z)-Octadecenoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52453 | Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt) | - | >98.00% | |
A peptide orexin receptor 1 agonist | ||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | - | >98.00% | |
A Bax inhibitor | ||||
| GC52490 | Glucagon (hydrochloride) | 19179-82-9 | >95.00% | |
A peptide hormone | ||||
| GC52493 | Glucosylceramide (bovine buttermilk) | - | >98.00% | |
A sphingolipid | ||||
| GC52496 | Sulfatide (bovine) (sodium salt) | - | >95.00% | |
A mixture of isolated bovine sulfatides | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC52502 | Peptide YY (3-36) (trifluoroacetate salt) | - | >95.00% | |
A satiety hormone | ||||
| GC52504 | Human Vitamin D Receptor Reporter Assay System | - | >98% | |
A nuclear receptor cell-based reporter assay | ||||
| GC52506 | Ghrelin (human) (trifluoroacetate salt) | - | >98.00% | |
A growth hormone releasing peptide | ||||
| GC52507 | Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A hypothalamic neuropeptide | ||||
| GC60311 | PTUPB | 1287761-01-6 | >98.00% | |
PTUPB is a novel dual COX-2 and sEH inhibitor with IC 50 values of 1.26 nM and 0.9 μM, respectively. | ||||
| GC60871 | Gemigliptin tartrate | 1374639-74-3 | >98.00% | |
Gemigliptin tartrate is a potent, selective and long-acting dipeptidyl peptidase 4 (DPP4) inhibitor with a K i of 7.25nM and an IC 50 value of 10.3nM. | ||||
| GC60997 | Lixisenatide acetate | 1997361-87-1 | >98.50% | |
Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). | ||||
| GC64119 | Saponarin | 20310-89-8 | >98% | |
Saponarin is a natural flavonoid isolated from Gypsophila trichotoma, with antioxidant, anti-inflammatory and hepatoprotective activities. | ||||
| GC69439 | Mazdutide | 2259884-03-0 | >99.00% | |
Mazdutide is a long-acting dual agonist of the glucagon-like peptide-1 receptor (GLP-1R; K i =28.6nM) and the glucagon receptor (GCGR; K i =17.7nM). | ||||
| GC70855 | LSN3318839 | 2764704-18-7 | >99.00% | |
LSN3318839 is an orally efficacious positive allosteric modulator of the glucagon-like peptide-1 receptor (GLP-1R). | ||||
| GC72096 | Bamadutide | 1596343-09-7 | >99.00% | |
Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist. | ||||
| GC72222 | Survodutide | 2805997-46-8 | >99.50% | |
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. | ||||
| GC90363 | 10(11)-Cl-BBQ | - | >95.00% | |
A mixture that acts as an AhR agonist | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
A metabolite of cortisol | ||||